Amina Zoubeidi

Also affiliated with University of British Columbia, The Prostate Centre

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1”.

Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.1905384117

N/A

0DataRank · unranked

144 citations

Meghan A. Rice, Abel Bermudez, Fernando Jose Garcia-Marques, Merve Aslan, Shiqin Liu +17 more

Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer

Nature Communications(2021)10.1038/s41467-021-22139-7

N/A

0DataRank · unranked

171 citations

David Y. Takeda, Ji-Heui Seo, Justin H. Hwang, Sheng-Yu Ku, Rand Arafeh +36 more

CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer

Nature Communications(2021)10.1038/s41467-021-21867-0

N/A

0DataRank · unranked

66 citations

Fraser Soares, Ji‐Han Xia, Yue Yang, Jing Li, Haiyang Guo +27 more

Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer

Nature Communications(2021)10.1038/s41467-021-26612-1

N/A

0DataRank · unranked

36 citations

Aashi Chaturvedi, Sarah A. Munro, Samuel P. Pitzen, Alexander Ling, Weijie Zhang +29 more

Reciprocal deregulation of NKX3.1 and AURKA axis in castration-resistant prostate cancer and NEPC models

Journal of Biomedical Science(2021)10.1186/s12929-021-00765-z

N/A

0DataRank · unranked

8 citations

Mohini Kamra, Amina Zoubeidi, Kavita Shah, Moloud Aflaki Sooreshjani

Tribbles 2 confers enzalutamide resistance in prostate cancer by promoting lineage plasticity

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.26.437250

N/A

0DataRank · unranked

2 citations

Indra Adrianto, Craig Rogers, Shirish M. Gadgeel, Dhananjay Chitale, Joshi J. Alumkal +4 more

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-1123

N/A

0DataRank · unranked

67 citations

Shuang G. Zhao, Samuel Levy, Meng Zhang, Yuhong Ning, Raunak Shrestha +58 more

Androgen receptor inhibition induces metabolic reprogramming and increased reliance on oxidative mitochondrial metabolism in prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.31.494200

N/A

0DataRank · unranked

2 citations

Jenna M. Giafaglione, Anthony E. Jones, Nicholas M. Nunley, Takao Hashimoto, Amelie M.L. Delcourt +16 more

The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0225

N/A

0DataRank · unranked

126 citations

Amina Zoubeidi, Himisha Beltran, Luke A. Selth, Alastair Davies

MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer

Cell Reports(2023)10.1016/j.celrep.2023.113221

N/A

0DataRank · unranked

33 citations

Jenna M. Giafaglione, Anthony E. Jones, Nicholas M. Nunley, Takao Hashimoto, Amelie M.L. Delcourt +20 more

Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

Cancer Research(2023)10.1158/0008-5472.can-23-0883

N/A

0DataRank · unranked

15 citations

Salma Ben‐Salem, Nidhi Singh, Gaurav Chauhan, Anja Rabljenovic, Vishwa Vaghela +27 more

A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0196

N/A

0DataRank · unranked

4 citations

Jeffrey A. Schneider, Susan Ha, Rachel Ruoff, Luiza Doro Pereira, Joseph Puccini +13 more

Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer

Nature Genetics(2024)10.1038/s41588-024-01826-3

N/A

0DataRank · unranked

38 citations

Matthew L. Bootsma, Stanley Zhou, Raunak Shrestha, Thaidy Moreno-Rodriguez, Arian Lundberg +41 more

UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas

Cell Reports Medicine(2024)10.1016/j.xcrm.2023.101381

N/A

0DataRank · unranked

31 citations

Timothy Chai, Fernando Jose Garcia-Marques, Qingqing Yin, En‐Chi Hsu, Michelle Shen +25 more

Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiation

Cancer Cell(2025)10.1016/j.ccell.2025.03.027

N/A

0DataRank · unranked

23 citations

Jiacheng Guo, Xin Xu, Xinpei Ci, Yulin Mo, Yakup Kohen +26 more

Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors

Acta Pharmaceutica Sinica B(2025)10.1016/j.apsb.2025.01.007

N/A

0DataRank · unranked

12 citations

Yatian Yang, Hongye Zou, Yang Yang, Xingling Zheng, Eva Corey +6 more

Circadian regulator REV-ERBα is a master regulator of tumor lineage plasticity and an effective therapeutic target

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2513468122

N/A

0DataRank · unranked

0 citations

Yatian Yang, Hongye Zou, Demin Cai, Eva Corey, Amina Zoubeidi +5 more